Applied DNA Sciences, Inc. (APDN) announced that on July 2, 2025, it received written notice from The Nasdaq Stock Market LLC.
The notice confirmed that the company has regained compliance with Nasdaq Listing Rule 5550, which requires a minimum bid price of $1.00 per share.
Applied DNA Sciences is now in full compliance with the Nasdaq Capital Market’s listing requirements.
Consequently, the hearing before the Nasdaq Hearings Panel, originally scheduled for July 15, 2025, has been cancelled.
The company’s securities will continue to be listed and traded on The Nasdaq Capital Market.
